These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38996486)

  • 1. Immune mechanisms in fibrotic interstitial lung disease.
    Kamiya M; Carter H; Espindola MS; Doyle TJ; Lee JS; Merriam LT; Zhang F; Kawano-Dourado L; Sparks JA; Hogaboam CM; Moore BB; Oldham WM; Kim EY
    Cell; 2024 Jul; 187(14):3506-3530. PubMed ID: 38996486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities.
    Hernandez-Gonzalez F; Pietrocola F; Cameli P; Bargagli E; Prieto-González S; Cruz T; Mendoza N; Rojas M; Serrano M; Agustí A; Faner R; Gómez-Puerta JA; Sellares J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells.
    Nakamura Y; Niho S; Shimizu Y
    Cells; 2024 May; 13(11):. PubMed ID: 38891026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
    Kawano-Dourado L; Kulkarni T; Ryerson CJ; Rivera-Ortega P; Baldi BG; Chaudhuri N; Funke-Chambour M; Hoffmann-Vold AM; Johannson KA; Khor YH; Montesi SB; Piccari L; Prosch H; Molina-Molina M; Sellares Torres J; Bauer-Ventura I; Rajan S; Jacob J; Richards D; Spencer LG; Wendelberger B; Jensen T; Quintana M; Kreuter M; Gordon AC; Martinez FJ; Kaminski N; Cornelius V; Lewis R; Adams W; Jenkins G;
    Thorax; 2024 Jul; 79(8):788-795. PubMed ID: 38448221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
    Papanikolaou IC; Boki KA; Giamarellos-Bourboulis EJ; Kotsaki A; Kagouridis K; Karagiannidis N; Polychronopoulos VS
    Immunol Lett; 2015 Feb; 163(2):179-86. PubMed ID: 25540922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms.
    Malaviya R; Kipen HM; Businaro R; Laskin JD; Laskin DL
    Toxicol Appl Pharmacol; 2020 Dec; 409():115272. PubMed ID: 33031836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease.
    Sgalla G; Walsh SLF; Sverzellati N; Fletcher S; Cerri S; Dimitrov B; Nikolic D; Barney A; Pancaldi F; Larcher L; Luppi F; Jones MG; Davies D; Richeldi L
    BMC Pulm Med; 2018 Jun; 18(1):103. PubMed ID: 29914454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.
    Goobie GC; Ryerson CJ; Johannson KA; Schikowski E; Zou RH; Khalil N; Marcoux V; Assayag D; Manganas H; Fisher JH; Kolb MRJ; Gibson KF; Kass DJ; Zhang Y; Lindell KO; Nouraie SM
    Am J Respir Crit Care Med; 2022 Feb; 205(4):459-467. PubMed ID: 34818133
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.
    Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y
    Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease.
    Goobie GC; Carlsten C; Johannson KA; Khalil N; Marcoux V; Assayag D; Manganas H; Fisher JH; Kolb MRJ; Lindell KO; Fabisiak JP; Chen X; Gibson KF; Zhang Y; Kass DJ; Ryerson CJ; Nouraie SM
    JAMA Intern Med; 2022 Dec; 182(12):1248-1259. PubMed ID: 36251286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease.
    Pillai M; Olson AL; Huie TJ; Solomon JJ; Fernandez-Perez ER; Brown KK; Hanna P; Lee-Chiong T; Swigris JJ
    Respir Med; 2012 Jul; 106(7):1033-9. PubMed ID: 22521226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology, Radiology, and Genetics of Interstitial Lung Disease in Patients With Shortened Telomeres.
    Cecchini MJ; Tarmey T; Ferreira A; Mangaonkar AA; Ferrer A; Patnaik MM; Wylam ME; Jenkins SM; Spears GM; Yi ES; Hartman TE; Scott JP; Roden AC
    Am J Surg Pathol; 2021 Jul; 45(7):871-884. PubMed ID: 33935155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
    Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R
    Front Immunol; 2021; 12():595811. PubMed ID: 33859634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstital lung disease in ANCA vasculitis.
    Alba MA; Flores-Suárez LF; Henderson AG; Xiao H; Hu P; Nachman PH; Falk RJ; Charles Jennette J
    Autoimmun Rev; 2017 Jul; 16(7):722-729. PubMed ID: 28479484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia.
    Amenomori M; Mukae H; Sakamoto N; Kakugawa T; Hayashi T; Hara A; Hara S; Fujita H; Ishimoto H; Ishimatsu Y; Nagayasu T; Kohno S
    Respir Med; 2010 Jun; 104(6):895-901. PubMed ID: 20129768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of fibrosis in interstitial lung disease.
    Burgy O; Bellaye PS; Beltramo G; Goirand F; Bonniaud P
    Curr Opin Pulm Med; 2020 Sep; 26(5):429-435. PubMed ID: 32769673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry.
    Behr J; Bonella F; Günther A; Koschel D; Prasse A; Pittrow D; Klotsche J; Kreuter M;
    BMC Pulm Med; 2023 Feb; 23(1):64. PubMed ID: 36774483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.